设为首页|加入收藏|英文版

总体介绍

首页 > 广东省中医药科学院 > 总体介绍

中医药防治慢性肾脏病研究团队

2017/4/20 8:57:01字号:T|T

    广东省中医院肾病研究室是依托于广东省中医院肾病中心、隶属于中国中医药科学院广东分院、广东省中医药科学院的肾脏病专门研究机构,。广东省中医院肾病中心是慢性肾脏病国家中医药临床基地。中心成立与1994年,现拥有4个住院病区150张病床;4个血液透析中心120台血透机;2个腹膜透析中心;5个专科门诊,1个慢性病管理门诊。肾病研究室拥有专业的研究队伍和设备先进的专科实验室。致力于中医药防治慢性肾脏疾病疗效及安全性的临床研究、慢性肾脏病进展风险预测及中医药调控以及慢性肾脏病中医药防治机理的研究,近5年来,在国家科技部的资助下,我们先后开展了3项大型的多中心临床研究(包括122家中心的RCT126家中心的Non-randomized Control Trail 14家中心的 Registration Research),在国家自然科学基金和广东省科技厅的资助下,我们围绕主攻方向开展了一系列基础研究。目前,现在研课题20余项,科研经费2000余万元。

Nephrology Institute of Guangdong Provincial Hospital of Chinese Medicine (NIGH-CM) is a specialized institution that relies on Nephrology Center of Guangdong Provincial Hospital of Chinese Medicine and attaches to Guangdong Branch of China Academy of Traditional Chinese Medicine and Guangdong Provincial Academy of Traditional Chinese Medicine. Nephrology Center of Guangdong provincial hospital of Chinese Medicine is the Clinical research base of national traditional Chinese Medicine of chronic kidney disease(CKD). The center was established in 1994, includes 4 inpatient wards with 150 beds,4 hemodialysis unit with 120 machines,2 peritoneal dialysis unit,5 outpatient clinics & 1 chronic disease management clinic(follow-up clinic).NIGH-CM own a professional research team and a specialist laboratory with advanced equipment. NIGH-CM engages in clinical trials on efficacy and safety assessment of CM therapies on CKD,progress risk prediction of CKD & regulation and control with CM, and the mechanism of CM on CKD. In the past 5 years, supported by Ministry of Science and Technology of People1s Republic of China, we developed 3 large multi-center clinical trials on CKD (include a 22 center RCT, a 26 center Non-randomized control trial and a 4 centers registration research).And supported by the National Nature Science Foundation of China.(NSFC) and Guangdong Provincial Department of Science and technology, we carried out a series fundamental researches focus on the above mentioned direction.  At the present, we have more than 20 research grants and about 2000 million RMB research funds.

我们的研究团队 Our Research Team

   
     刘旭生,医学硕士。教授。广东省中医院肾脏病中心主任、学科带头人。博士生研究生导师。主攻方向中医药防治慢性肾脏病的疗效及安全性评价。擅长慢性肾脏病多中心临床研究的组织与实施。承担国家科技部及广东省科技厅资助项目
6项,获得科研经费1000余万元。培养硕博士研究生30余名。发表SCI论文10余篇。

    Xusheng LiuMaster of Medicine. Professor. Director and district leader of Nephrology Center of Guangdong provincial hospital of Chinese Medicine. Doctoral supervisor. He continued to devote himself to research on efficacy/effectiveness and safety assessment of Chinese medical therapies on CKD and is skilled in organization and implementation of multi-center clinical trials. He obtained 6 research grants with more than 10 million RMB research funds supported by Ministry of Science and Technology of P.R. China and Guangdong Provincial Department of Science and Technology and Guangdong Provincial Department of Science and Technology. He has tutored more than 30 master degree candidates and doctoral candidates and published more than 10 SCI included papers.

  
   毛炜,医学博士,教授。肾病研究团队PI。博士研究生导师,博士后合作教授。主攻方向慢性肾脏病进展风险预测及中医药调控、慢性肾脏病中医药防治机理研究。擅长慢性肾脏病临床研究、系统生物学研究设计。承担国家自然科学基金、国家科技部及广东省科技厅资助项目4项。发表SCI论文10篇。培养硕士研究生24名,博士研究生7名,博士后2名。

   Wei Mao,、Ph. D. Professor. Principle Investigator (PI) of NIGH-CM. Doctoral supervisor and postdoctoral tutor. Her major directions of research include progress risk prediction of CKD & regulation and control with CM, and the mechanism of CM on CKD. She is expert in designation of clinical trials and system biological research.She has obtained 4 research grants respectively from the National Nature Science Foundation of China. (NSFC) and Ministry of Science and Technology of P.R. China and Guangdong Provincial Department of Science and technology. She has published 10 SCI included papers and supervised 24 Master students,7 PhD students and 2 postdoctoral fellows.



    徐鹏,医学博士,副研究员,硕士研究生导师。主要从事中医药防治慢性肾脏病临床与基础研究工作。尤其在慢性肾脏病及代谢性疾病的系统生物学研究方面有较深造诣。
      Peng Xu, Ph. D. Associate Professor. Master supervisor. He is involved in clinical and basic research on the prevention and treatment of chronic kidney disease with Chinese Medicine therapies. He is expert in the system biological research on Chronic kidney diseases and metabolic diseases.

    张蕾 医学博士,副研究员澳洲昆士兰大学附属访问学者主攻方向慢性肾脏病疾病进展风险预测与中医药防治,擅长肾脏病临床试验方案设计与评估,肾脏病登记研究数据库构建及数据分析。

    Lei Zhang, PH.D, Associate Professor, Visiting scholar at Princess Alexandra HospitalThe university of Queensland, in Brisbane, Australia. She is involved in clinical trials about the prediction of risk factors of Chronic Kidney Disease progression and traditional medicine treatment on them. She currently works on the clinical trial design and evaluation, chronic kidney disease registry data analysis.


    黎创 医学博士,主治医师,主攻方向中医药防治慢性肾脏病,擅长肾脏病临床试验方案的设计、安全监察、质量控制及疗效评估。
       Chuang LiPH.D, Nephrologist. She is involved in clinical trials about treatment, precaution and outcomes measurement on chronic kidney disease . She is responsible for design the study proposal, data and safety monitoring, quality control and effective evaluation of Traditional Chinese Medicine.

    卢钊宇,医学硕士,主治医师。主攻方向肾脏损伤修复及中医药调控机制。擅长细胞、分子生物学研究。

    Zhaoyu Lu. Master of Medicine. Attending physician. He is involved in research on the damage repair of kidney and the mechanism of Chinese medical regulation. He is skilled in cellular and molecular biological research.



     田瑞敏,医学硕士。实习研究员。主攻方向肾脏损伤修复及中医药调控机制。擅长干细胞研究技术。

         Ruimin Tian, Master of Medicine. Intern researcher. Her major research direction is the damage repair of kidney and the mechanism of Chinese medical regulation. She is good at stem cell research.

实验室和设备 lab and equipment


我们的成果 Our Achievement

    长期随访的慢性肾脏病患者患者超过1700人包括200名腹膜透析患者;制定了1项慢性肾脏病患者健康教育地方标准、科研经费2000余万元;近3年发表SCI论文20余篇,EI论文5篇;获得专利5项。

    Over 1,700 CKD patients were included in long-term follow-up, including 200 peritoneal dialysis patients.Set up 1 provincial CKD patients education Standard. Obtain more than 20 million RMB research funding. Published more than 20 SCI included papers & 5 EI included papers in recent 3 years and obtained 5 patents

今后研究方向 Main Directions of Future Research

    中医药治疗慢性肾脏病的循证医学研,中医药治疗慢性肾脏病疗效与安全性评价的临床研究。慢性肾脏病进展风险预测与中医药调控研究以及中医药治疗慢性肾脏病的机制研究。

     Evidence-based study on CM therapies on CKD, Clinical trials on the efficacy and safety assessment of CM therapies on CKDProgressive risk prediction of CKD & regulation and control with CMThe mechanism of CM on CKD.



首页|网站地图|法律申明|友情链接|招聘信息|供应商管理|名老中医学术交流|中医健康管理|中医医案管理 |知识管理|在线考试